With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing program? Is it truly supporting low-income communities as it was intended to? A recent article from the New York Times shows how program flaws and a lack of serious oversight…

For vulnerable patients across America, getting the 340B Drug Pricing Program right could be the difference between receiving lifesaving care or not. If it was working how Congress intended when it was created three decades ago, the 340B program would help vulnerable communities access their medications. …

With the unparalleled effects of the COVID-19 pandemic, it makes sense that health care is a top concern for Americans. The virus has wreaked havoc in all corners of the nation. People young and old have all experienced disruption to their livelihoods, but the pandemic has disproportionately impacted underserved communities…

On Wednesday, May 26, the Alliance for Integrity and Reform of 340B hosted its annual Stakeholder Summit to discuss the 340B Drug Pricing Program and what must be done to save the program from fraud and misuse. Attendees were unanimous in their proposed solution: focus on the patient. The three-part…

Over the last year, the pandemic has upended our normal lives, exacerbated health inequities, and tested the resiliency of our communities as we deal with the public health crisis and subsequent economic fallout. We have also seen a strong reliance on safety-net programs to stem the hardship faced by many…

As the 116th Congress gets underway, health care is top of mind not only for lawmakers, but also for Americans everywhere. According to a recent Gallup poll, 6 in 10 Americans say they are concerned about the increasing cost of their personal health care. One driver of consumer angst is…

Over the past year, there has been a growing body of evidence that the 340B program doesn’t always best serve vulnerable or uninsured patient populations. Evidence has also raised questions about how some hospitals use the 340B program. With 2019 approaching, we invite you to get caught up with key…

The 340B drug discount program — a vital safety-net program created to help millions of vulnerable or uninsured patients receive care — is no longer benefiting many of the patients it was meant to serve. That’s according to mounting findings from congressional investigations, independent economists, and government watchdogs. Two new…

When a hospital becomes newly eligible for what is intended to be a safety-net program, you might expect to see the hospital serving more indigent or uninsured. For example, you would expect to see the amount of charity care the hospital provides increase with the additional revenue a hospital gets…